These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 23617697)
1. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability. Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-hepatocellular carcinoma activity of novel O Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O Kang F; Ai Y; Zhang Y; Huang Z Eur J Med Chem; 2018 Apr; 149():269-280. PubMed ID: 29501947 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance. Maciag AE; Holland RJ; Robert Cheng YS; Rodriguez LG; Saavedra JE; Anderson LM; Keefer LK Redox Biol; 2013; 1(1):115-24. PubMed ID: 24024144 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs. Chakrapani H; Kalathur RC; Maciag AE; Citro ML; Ji X; Keefer LK; Saavedra JE Bioorg Med Chem; 2008 Nov; 16(22):9764-71. PubMed ID: 18930407 [TBL] [Abstract][Full Text] [Related]
7. O Li Q; Zou P; Sun J; Chen L Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794 [TBL] [Abstract][Full Text] [Related]
8. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Shami PJ; Saavedra JE; Wang LY; Bonifant CL; Diwan BA; Singh SV; Gu Y; Fox SD; Buzard GS; Citro ML; Waterhouse DJ; Davies KM; Ji X; Keefer LK Mol Cancer Ther; 2003 Apr; 2(4):409-17. PubMed ID: 12700285 [TBL] [Abstract][Full Text] [Related]
9. Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs. Maciag AE; Nandurdikar RS; Hong SY; Chakrapani H; Diwan B; Morris NL; Shami PJ; Shiao YH; Anderson LM; Keefer LK; Saavedra JE J Med Chem; 2011 Nov; 54(22):7751-8. PubMed ID: 22003962 [TBL] [Abstract][Full Text] [Related]
10. NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway. Liu L; Fu J; Li T; Cui R; Ling J; Yu X; Ji H; Zhang Y Eur J Pharmacol; 2012 Sep; 691(1-3):61-8. PubMed ID: 22824464 [TBL] [Abstract][Full Text] [Related]
11. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs. Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma. Abou-Salim MA; Shaaban MA; Abd El Hameid MK; Elshaier YAMM; Halaweish F Bioorg Chem; 2019 Apr; 85():515-533. PubMed ID: 30807895 [TBL] [Abstract][Full Text] [Related]
13. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents. Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516 [TBL] [Abstract][Full Text] [Related]
14. Glutathione S-Transferase π-Activatable O Huang Z; Wu J; Zou Y; Yuan H; Zhang Y; Fei Y; Bhardwaj A; Kaur J; Knaus EE; Zhang Y J Med Chem; 2018 Mar; 61(5):1833-1844. PubMed ID: 29420887 [TBL] [Abstract][Full Text] [Related]
15. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells. BMC Cancer; ; . PubMed ID: 22462810 [TBL] [Abstract][Full Text] [Related]